Chitosan functionalized doxorubicin loaded poly(methacrylamide) based copolymeric nanoparticles for enhanced cellular internalization and in vitro anticancer evaluation
Priya Manhas,Ceren Cokca,Rohit Sharma,Kalina Peneva,Nishima Wangoo,Deepika Sharma,Rohit K. Sharma
DOI: https://doi.org/10.1016/j.ijbiomac.2024.129242
IF: 8.2
2024-01-10
International Journal of Biological Macromolecules
Abstract:Doxorubicin (Dox), a chemotherapeutic agent, encounters challenges such as a short half-life, dose-dependent toxicity, and low solubility. In this context, the present study involved the fabrication of N -(2-hydroxypropyl)methacrylamide (HPMA) and N -(3-aminopropyl)methacrylamide (APMA) bearing P(HPMA- s -APMA) copolymeric nanoparticles (P(HPMA- s -APMA) NPs) and their investigation for efficient delivery of Dox. Furthermore, the synthesized nanoparticles (NPs) were coated with chitosan (Cht) to generate positively charged nanoformulations. The prepared formulations were evaluated for particle size, morphology, surface charge analysis, percentage encapsulation efficiency (EE%), and drug release studies. The anticancer activity of Cht-P(HPMA- s -APMA)-Dox NPs was assessed in the HeLa cancer cell line. The prepared P(HPMA- s -APMA)-Dox NPs exhibited an average particle size of 240–250 nm. Chitosan decorated P(HPMA- s -APMA)-Dox NPs displayed a significant increase in particle size, and the zeta potential shifted from negative to positive. The EE% for Cht-P(HPMA-s-APMA)-Dox NPs was calculated to be 68.06 %. The drug release studies revealed a rapid release of drug from Cht-P(HPMA- s -APMA)-Dox NPs at pH 4.8 than pH 7.4, demonstrating the pH-responsiveness of nanoformulation. Furthermore, the cell viability assay and internalization studies revealed that Cht-P(HPMA-s-APMA)-Dox NPs had a high cytotoxic response and significant cellular uptake. Hence, the Cht-P(HPMA- s -APMA)-Dox NPs appeared to be a suitable nanocarrier for effective, and safe chemotherapy.
polymer science,biochemistry & molecular biology,chemistry, applied